WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function.
Development of hematopoietic cells depends on a dynamic actin cytoskeleton. Here we demonstrate that expression of the cytoskeletal regulator WASP, mutated in the Wiskott-Aldrich syndrome, provides selective advantage for the development of naturally occurring regulatory T cells, natural killer T cells, CD4(+) and CD8(+) T lymphocytes, marginal zone (MZ) B cells, MZ macrophages, and platelets. To define the relative contribution of MZ B cells and MZ macrophages for MZ development, we generated wild-type and WASP-deficient bone marrow chimeric mice, with full restoration of the MZ. However, even in the presence of MZ macrophages, only 10% of MZ B cells were of WASP-deficient origin. We show that WASP-deficient MZ B cells hyperproliferate in vivo and fail to respond to sphingosine-1-phosphate, a crucial chemoattractant for MZ B-cell positioning. Abnormalities of the MZ compartment in WASP(-/-) mice lead to aberrant uptake of Staphylococcus aureus and to a reduced immune response to TNP-Ficoll. Moreover, WASP-deficient mice have increased levels of "natural" IgM antibodies. Our findings reveal that WASP regulates both development and function of hematopoietic cells. We demonstrate that WASP deficiency leads to an aberrant MZ that may affect responses to blood-borne pathogens and peripheral B-cell tolerance.
Westerberg
Lisa S
LS
Gastrointestinal Unit and the Center for the Study of Inflammatory Bowel Diseases, Massachusetts General Hospital, Boston, USA.
de la Fuente
Miguel A
MA
Wermeling
Fredrik
F
Ochs
Hans D
HD
Karlsson
Mikael C I
MC
Snapper
Scott B
SB
Notarangelo
Luigi D
LD
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology*; D049109:Cell Proliferation / Q000187:drug effects; D002630:Chemotactic Factors / Q000276:immunology / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000276:immunology*; D006706:Homeostasis / Q000187:drug effects / Q000276:immunology*; D007075:Immunoglobulin M / Q000276:immunology; D008246:Lysophospholipids / Q000276:immunology / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D018345:Mice, Knockout; D013110:Sphingosine / Q000031:analogs & derivatives / Q000276:immunology / Q000494:pharmacology; D013211:Staphylococcus aureus / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D051316:Wiskott-Aldrich Syndrome Protein / Q000235:genetics / Q000276:immunology*
D002630:Chemotactic Factors; D007075:Immunoglobulin M; D008246:Lysophospholipids; C495768:Was protein, mouse; D051316:Wiskott-Aldrich Syndrome Protein; C060506:sphingosine 1-phosphate; D013110:Sphingosine
J Pediatr. 1994 Dec;125(6 Pt 1):876-85
7996359
Clin Exp Immunol. 2005 Feb;139(2):297-305
15654828
Nat Immunol. 2008 Jan;9(1):54-62
18037889
Blood. 2003 Aug 15;102(4):1282-9
12730112
Blood. 2002 Aug 15;100(4):1208-14
12149199
Expert Opin Biol Ther. 2008 Feb;8(2):181-90
18194074
J Exp Med. 2003 Jul 21;198(2):333-40
12874264
Immunol Rev. 2004 Feb;197:192-205
14962196
Nat Rev Immunol. 2005 Aug;5(8):606-16
16056254
Blood. 2001 Mar 15;97(6):1598-603
11238097
Blood. 2003 Mar 15;101(6):2159-66
12433691
Blood. 1995 May 1;85(9):2471-7
7537115
J Exp Med. 2007 Feb 19;204(2):369-80
17296785
J Clin Immunol. 2007 Nov;27(6):634-9
17690954
Curr Opin Hematol. 2008 Jan;15(1):30-6
18043243
Annu Rev Immunol. 2007;25:297-336
17150027
Blood. 2004 Sep 1;104(5):1270-2
15142877
Immunity. 1995 Sep;3(3):283-99
7552994
J Leukoc Biol. 2005 Jun;77(6):993-8
15774550
Gene Ther. 2007 Mar;14(5):415-28
17051251
Blood. 2007 Dec 15;110(13):4278-84
17673604
Annu Rev Immunol. 2005;23:161-96
15771569
Br J Haematol. 1998 Jun;101(4):659-65
9674738
Immunity. 1998 Jul;9(1):81-91
9697838
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15424-9
17878299
Immunity. 2003 May;18(5):675-85
12753744
Clin Immunol. 2007 Jul;124(1):41-8
17512803
J Immunol. 2004 Mar 15;172(6):3620-7
15004164
Blood. 2004 Dec 1;104(12):3454-62
15308573
Blood. 1997 Oct 1;90(7):2680-9
9326235
Blood. 2005 Feb 15;105(4):1590-7
15494425
Bone Marrow Transplant. 2006 Nov;38(10):671-9
17013426
Blood. 2003 Nov 1;102(9):3108-16
12855574
Science. 2002 Jul 19;297(5580):409-12
12130787
J Exp Med. 2007 Feb 19;204(2):381-91
17296786
J Exp Med. 2007 Oct 1;204(10):2259-65
17893199
Blood. 2005 Feb 1;105(3):1144-52
15383456
Am J Surg Pathol. 1999 Feb;23(2):182-91
9989845
Science. 1993 Jul 16;261(5119):358-61
8332901
Annu Rev Immunol. 2001;19:595-621
11244048
Expert Opin Biol Ther. 2007 Oct;7(10):1575-82
17916049
Blood. 2004 Jan 15;103(2):676-8
14504083
J Clin Invest. 2007 Feb;117(2):407-18
17218989
Nat Immunol. 2004 Jul;5(7):713-20
15184895
J Immunol. 2001 Apr 15;166(8):4831-4
11290758
Hum Gene Ther. 2002 Jun 10;13(9):1039-46
12067437
Blood. 2008 Jan 1;111(1):439-45
17901250
Exp Hematol. 2006 Sep;34(9):1161-9
16939809
J Immunol. 1998 Jul 15;161(2):1026-33
9670984